Methylenomycin B
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Antibiotics |
Catalog number | BBF-01928 |
CAS | 52775-77-6 |
Molecular Weight | 122.16 |
Molecular Formula | C8H10O |
Online Inquiry
Description
Methylenomycin b is a cyclopentanone derived antibiotic produced by Streptomyces violaceoruber 2416 that is effective against both Gram-negative and Gram-positive bacteria.
Specification
Synonyms | 2,3-Dimethyl-5-methylene-2-cyclopenten-1-one |
IUPAC Name | 2,3-dimethyl-5-methylidenecyclopent-2-en-1-one |
Canonical SMILES | CC1=C(C(=O)C(=C)C1)C |
InChI | InChI=1S/C8H10O/c1-5-4-6(2)8(9)7(5)3/h2,4H2,1,3H3 |
InChI Key | YDXIEAHUYZKJOH-UHFFFAOYSA-N |
Properties
Appearance | Colorless Oil |
Antibiotic Activity Spectrum | Gram-positive bacteria; Gram-negative bacteria |
Boiling Point | 192.4±30.0°C at 760 mmHg |
Density | 1.0±0.1 g/cm3 |
Reference Reading
1. Waking up Streptomyces secondary metabolism by constitutive expression of activators or genetic disruption of repressors
Bertrand Aigle, Christophe Corre Methods Enzymol. 2012;517:343-66. doi: 10.1016/B978-0-12-404634-4.00017-6.
Streptomycete bacteria are renowned as a prolific source of natural products with diverse biological activities. Production of these metabolites is often subject to transcriptional regulation: the biosynthetic genes remain silent until the required environmental and/or physiological signals occur. Consequently, in the laboratory environment, many gene clusters that direct the biosynthesis of natural products with clinical potential are not expressed or at very low level preventing the production/detection of the associated metabolite. Genetic engineering of streptomycetes can unleash the production of many new natural products. This chapter describes the overexpression of pathway-specific activators, the genetic disruption of pathway-specific repressors, and the main strategy used to identify and characterize new natural products from these engineered Streptomyces strains.
2. Unique Physiological and Genetic Features of Ofloxacin-Resistant Streptomyces Mutants
Kanata Hoshino, Ryoko Hamauzu, Hiroyuki Nakagawa, Shinya Kodani, Takeshi Hosaka Appl Environ Microbiol. 2022 Feb 8;88(3):e0232721. doi: 10.1128/aem.02327-21. Epub 2021 Dec 22.
New antimicrobial agents are urgently needed to combat the emergence and spread of multidrug-resistant bacteria. Activating the cryptic biosynthetic gene clusters for actinomycete secondary metabolites can provide essential clues for research into new antimicrobial agents. An effective method for this purpose is based on drug resistance selection. This report describes interesting results for drug resistance selection using antibiotics that target DNA replication and can effectively potentiate secondary metabolite production by actinomycetes. Ofloxacin-resistant mutants were isolated from five different streptomycetes. Ofloxacin is an antibiotic that binds to DNA complexes and type II topoisomerase, causing double-stranded breaks in bacterial chromosomes. Physiological and genetic characterization of the mutants revealed that the development of ofloxacin resistance in streptomycetes leads to the emergence of various types of secondary metabolite-overproducing strains. In Streptomyces coelicolor A3(2), ofloxacin-resistant mutants that overproduced actinorhodin, undecylprodigiosin, or carotenoid were identified. An ofloxacin-resistant mutant that overproduces methylenomycin A, whose biosynthetic gene cluster is located on the endogenous plasmid, SCP1, also was isolated. These observations indicate that ofloxacin resistance activates biosynthetic genes on both chromosomes and endogenous plasmids. We also identified the mutations that are probably involved in the phenotype of ofloxacin resistance and secondary metabolite overproduction in S. coelicolor A3(2). Furthermore, we observed an interesting phenomenon in which several ofloxacin-resistant mutants overproduced antibiotics in the presence of ofloxacin. Based on these results, we present the unique physiological and genetic characteristics of ofloxacin-resistant Streptomyces mutants and discuss the importance and potential development of the new findings. IMPORTANCE The abuse or overuse of antibacterial agents for therapy and animal husbandry has caused an increased population of antimicrobial-resistant bacteria in the environment. Consequently, fewer effective antimicrobials are now available. Due to the depleted antibiotic pipeline, pandemic outbreaks caused by antimicrobial-resistant bacteria are deeply concerning, and the development of new antibiotics is now an urgent issue. Promising sources of antimicrobial agents include cryptic biosynthetic gene clusters for secondary metabolites in streptomycetes and rare actinomycetes. This study's significance is the development of an unprecedented activation method to accelerate drug discovery research on a global scale. The technique developed in this study could allow for simultaneous drug discovery in different countries, maximizing the world's microbial resources.
3. Xanthocidin Derivatives from the Endophytic Streptomyces sp. AcE210 Provide Insight into Xanthocidin Biosynthesis
Nico Ortlieb, Karin Bretzel, Andreas Kulik, Julian Haas, Steffen Lüdeke, Nadine Keilhofer, Silvia Diane Schrey, Harald Gross, Timo Horst Johannes Niedermeyer Chembiochem. 2018 Dec 4;19(23):2472-2480. doi: 10.1002/cbic.201800467. Epub 2018 Nov 6.
Xanthocidin and six new derivatives were isolated from the endophytic Streptomyces sp. AcE210. Their planar structures were elucidated by 1D and 2D NMR spectroscopy as well as by HRMS. The absolute configuration of one compound was determined by using vibrational circular dichroism spectroscopy (VCD). The structural similarities of xanthocidin and some of the isolated xanthocidin congeners to the methylenomycins A, B, and C suggested that the biosynthesis of these compounds might follow a similar route. Feeding studies with isotopically labelled [13 C5 ]-l-valine showed that instead of utilizing acetyl-CoA as starter unit, which has been proposed for the methylenomycin biosynthesis, Streptomyces sp. AcE210 employs an isobutyryl-CoA starter unit, resulting in a branched side chain in xanthocidin. Further evidence for a comparable biosynthesis was given by the analysis of the genome sequence of Streptomyces sp. AcE210 that revealed a cluster of homologues to the mmy genes involved in methylenomycin biosynthesis.
Recommended Products
BBF-03915 | Clavulanate Potassium (1:1 mixture with silicon dioxide) | Inquiry |
BBF-04621 | Artemisinin | Inquiry |
BBF-03488 | Streptozotocin | Inquiry |
BBF-04624 | Sulbactam Sodium | Inquiry |
BBF-04301 | Tulathromycin A | Inquiry |
BBF-03904 | Nosiheptide | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳